R S M Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 1989.
1989 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About R S M Pharma Private Limited

R S M Pharma Private Limited, a active private limited company, was established on 30 March 1989 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85110KA1989PTC009974. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.

It upholds a compliant status. Employing 255 professional, Its leadership includes Sreekantiah Bangalore Deepak (Additional Director), Abhinav Choudhary (Additional Director), Venkatasubramanian Kishowre (Additional Director). Past directors included Champalal Nahar, Sudhindra Govinda Rao Mudhol, Gopal Sarda. It holds ₹60.00 Cr open charges and ₹67.88 Cr settled loans. Its latest AGM occurred on 16 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1St Floor, No.260/1/36/2C, Pattangere, Global Village Road, Near Metro Cash & C, Arry, Bangalore, Karnataka, 560059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1989PTC009974

  • Registration Number

    009974

  • Incorporation Date

    30 March 1989

  • Authorized Capital

    ₹1.50 Cr

  • Paid-Up Capital

    ₹1.50 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 36 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 60.00 Cr
  • Satisfied Charges ₹ 67.88 Cr
  • Revenue Growth **** 29.47%
  • Profit Growth **** 15.54%
  • Ebitda **** 23.09%
  • Net Worth 72.46%
  • Total Assets **** 19.40%
Company report

R S M Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into R S M Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at R S M Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sreekantiah Bangalore Deepak Additional Director 11 Feb 2025 Current
Abhinav Choudhary Additional Director 11 Nov 2025 Current
Venkatasubramanian Kishowre Additional Director 27 Nov 2025 Current
Sumitra Sachin Jadhav Additional Director 12 Jan 2026 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Aug 2018 Past
Pramod Abcsdd Director 23 Oct 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Additional Director 25 Sep 2024 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of R S M Pharma.

R S M Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.47% increase. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 72.46%.

R S M Pharma revenue growth over time
R S M Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 29.47%
*******
*******
*******
*******
Revenue from Operations
*******
 29.51%
*******
*******
*******
*******
Total Assets
*******
 19.40%
*******
*******
*******
*******
Profit or Loss
*******
 15.54%
*******
*******
*******
*******
Net Worth
*******
 72.46%
*******
*******
*******
*******
EBITDA
*******
 23.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of R S M Pharma?

In 2023, R S M Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹600,000,000.00

Satisfied Charges

₹678,800,000.00

Charges Breakdown by Lending Institutions
  • Others : 60.00 Cr
Latest Charge Details
Date Lender Amount Status
15 Feb 2022 Others ₹60.00 Cr Open
31 May 2019 Others ₹15.00 Cr Satisfied
31 Aug 2018 Others ₹10.00 Cr Satisfied
22 Jul 2013 The Hongkong And Shanghai Banking Corporation Ltd ₹20.00 Cr Satisfied
19 May 2010 Standard Chartered Bank ₹15.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at R S M Pharma?

R S M Pharma has a workforce of 255 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of R S M Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R S M Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on R S M Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Sumitra Sachin Jadhav was appointed as a Additional Director was appointed as a Additional Director on 12 Jan 2026 & has been associated with this company since 1 month 9 days . was completed.

  • Charges

    The activity A charge with Others of Rs. 60.00 Cr registered on 15 Feb 2022 with Charge ID 100546161 was modified on 01 Dec 2025. was completed.

  • Director Appointment

    Venkatasubramanian Kishowre was appointed as a Additional Director was appointed as a Additional Director on 27 Nov 2025 & has been associated with this company since 2 months 27 days . was recorded as a recent event.

  • Director Appointment

    Progress on Abhinav Choudhary was appointed as a Additional Director was appointed as a Additional Director on 11 Nov 2025 & has been associated with this company since 3 months 12 days . was documented.

  • Annual General Meeting

    R S M Pharma Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity R S M Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of R S M Pharma Private Limited?

The CIN of R S M Pharma Private Limited is U85110KA1989PTC009974.

Where is R S M Pharma Private Limited headquartered?

R S M Pharma Private Limited is headquartered at 1St Floor, No.260/1/36/2C, Pattangere, Global Village Road, Near Metro Cash & C, Arry, Bangalore, Karnataka, 560059.

When was R S M Pharma Private Limited incorporated?

R S M Pharma Private Limited was incorporated on 30 March 1989.

Who are the current directors of R S M Pharma Private Limited?

The current directors of R S M Pharma Private Limited are

What is the primary industry of R S M Pharma Private Limited?

The primary industry of R S M Pharma Private Limited is Trade.

Is R S M Pharma Private Limited a listed company?

R S M Pharma Private Limited is unlisted.

What is the capital structure of R S M Pharma Private Limited?

The authorized capital of R S M Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.

What is the compliance status of R S M Pharma Private Limited?

The compliance status of R S M Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available